| Bayer (Schweiz) AG - Betaferon, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | 53225 | | 02 | | Betaferon | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | L03AB08 | | Interferon Beta-1b | | 01.04.2003 | | |
| | Composition | | Praeparatio cryodesiccata: interferonum beta-1b ADNr 0.3 mg corresp. 9.6 Mio U.I., albuminum humanum, mannitolum, natrii hydroxidum q.s. ad pH, acidum hydrochloricum q.s. ad pH, pro vitro.
Solvens: natrii chloridum corresp. natrium 2.553 mg, aqua ad iniectabile q.s. ad solutionem pro 1.2 ml.
Solutio reconstituta: interferonum beta-1b ADNr 0.25 mg corresp. 8 Mio U.I., albuminum humanum, mannitolum, natrii chloridum, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium max. 2.955 mg. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| Interferonum Beta-1b Adnr | 0.3 mg |
| | BAG: Active Agent | Dose |
|---|
| Interferonum Beta-1b Adnr | 0.3 mg |
| | | | Inactive agents |
|---|
| Human Albumin | | Mannitol | | Sodium Hydroxide |
| |
| Solvens | | | Lyophilisate and solvent | | | | | | | | | BAG: Active Agent | Dose |
|---|
| Interferonum Beta-1b Adnr | 0.3 mg |
| | | | Inactive agents |
|---|
| Sodium Chloride |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 047 | Kombipackung(en) | 827.06 | 915.90 | B | SL | Yes |
|
|
